Active, not recruitingPhase 3NCT05367960
An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
Studying Fragile X syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Tetra Discovery Partners
- Principal Investigator
- Elizabeth Berry-Kravis, MDRush University Medical Center
- Intervention
- Zatolmilast/ BPN14770(drug)
- Enrollment
- 314 enrolled
- Eligibility
- 9-45 years · MALE
- Timeline
- 2022 – 2027
Study locations (17)
- Amnova Clinical Research, Irvine, California, United States
- Thompson Autism & Neurodevelopment Center - CHOC, Orange, California, United States
- MIND Institute UC Davis Medical Center, Sacramento, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- University of Miami, Miami, Florida, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- Rush University Medical Center, Chicago, Illinois, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Kennedy Krieger Institute, Baltimore, Maryland, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- U Mass, Worcester, Massachusetts, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Suburban Research Associates, Media, Pennsylvania, United States
- Clinic for Special Children, Strasburg, Pennsylvania, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05367960 on ClinicalTrials.govOther trials for Fragile X syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07493096Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal DisordersHealing Hope International
- RECRUITINGPHASE2NCT07209462Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)Mirum Pharmaceuticals, Inc.
- RECRUITINGNANCT06868979Optical Imaging in X-linked Disorders.Hospices Civils de Lyon
- RECRUITINGNANCT06740162Physical Activity and Community EmPOWERment ProjectUniversity of North Carolina, Chapel Hill
- RECRUITINGPHASE2NCT06081348Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental DisordersHolland Bloorview Kids Rehabilitation Hospital
- RECRUITINGNANCT06279858Probiotic Intervention for Microbiome Modifications and Clinical Improvements in Fragile X SyndromeSpecila hospital for cerebral palsy and developmental neurology
- RECRUITINGNANCT06088589Speech-in-noise Perception in Autism and Fragile XChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNANCT06139172Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)Rush University Medical Center